Clinical trial: Oral drug improves exercise capacity in teens with congenital heart defects

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects.

From http://besthealthnews.com/2019/11/clinical-trial-oral-drug-improves-exercise-capacity-in-teens-with-congenital-heart-defects/?utm_source=rss&utm_medium=rss&utm_campaign=clinical-trial-oral-drug-improves-exercise-capacity-in-teens-with-congenital-heart-defects

from
https://healthnews010.wordpress.com/2019/11/18/clinical-trial-oral-drug-improves-exercise-capacity-in-teens-with-congenital-heart-defects/

From https://aubreyflores.blogspot.com/2019/11/clinical-trial-oral-drug-improves.html

from
https://aubreyflores.wordpress.com/2019/11/18/clinical-trial-oral-drug-improves-exercise-capacity-in-teens-with-congenital-heart-defects/

From https://christinowlin.blogspot.com/2019/11/clinical-trial-oral-drug-improves.html

from
https://christinowlin.wordpress.com/2019/11/18/clinical-trial-oral-drug-improves-exercise-capacity-in-teens-with-congenital-heart-defects/